Search
for
Sort by
Research 121–150 of 1000+
- Under Development JAK Inhibitors for Dermatologic Diseases
- Alopecia areata – Current understanding and management
- Single‐cell transcriptomics reveals a senescence‐associated IL ‐6/ CCR6 axis driving radiodermatitis
- JAK 1-3 inhibitors and TYK-2 inhibitors in dermatology: Practical pearls for the primary care physician
- Case Report: Reversal of Long-Standing Refractory Diffuse Non-Scarring Alopecia Due to Systemic Lupus Erythematosus Following Treatment With Tofacitinib
- The Relative Efficacy and Safety of Monotherapies for Alopecia Areata: A Network Meta‐Analysis Study
- Refractory alopecia in lupus treated with tofacitinib — a case-based review
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- Improvement of Psoriasis, Psoriatic Arthritis, and Alopecia Universalis during Treatment with Tofacitinib: A Case Report
- Treatment of Crohn's Disease and Concomitant Alopecia Areata With Tofacitinib
- Alopecia universalis. Partial response to tofacitinib
- JAK INHIBITORS IN THE PATHOGENESIS OF ALOPECIA AREATA
- JAK INHIBITORS IN THE PATHOGENESIS OF ALOPECIA AREATA
- Ritlecitinib: Efficacy of a Novel Therapy for Severe Alopecia Areata in Patients Aged 12 Years and Older
- New Treatment Strategies in Management of Alopecia Areata: Review Article
- Alopecia areata
- Ann Robinson’s research reviews —12 May 2022
- Chemotherapy-Induced Alopecia Beyond Cytotoxicity: Hair Follicle Immune Privilege Collapse and JAK-STAT Signaling
- Alopecia areata: from immunopathogenesis to emerging therapeutic approaches
- Case Report of a Patient With Psoriasis Vulgaris, Psoriatic Arthritis and Alopecia Universalis Successfully Treated With Tofacitinib and Methotrexate
- Nouvelles thérapeutiques dans la prise en charge de l’alopécie androgénétique
- A Concise Review on Novel Drugs Applied in Treatment of Alopecia
- Update: baricitinib for alopecia areata
- Upadacitinib for Alopecia Areata in Different Backgrounds: A Case Series
- Alopecia Universalis Treated With Tofacitinib: The Role of JAK/STAT Inhibitors in Hair Regrowth
- Screening for latent infectious disease in patients with alopecia areata before initiating JAK inhibitors therapy: a single-center real-world retrospective study
- Treatment Patterns and Unmet Needs in the Management of Alopecia Areata: Results of a Physician’s Survey in the Middle East
- Overview of alopecia areata for managed care and payer stakeholders in the United States
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- SOCS1 and SOCS3 as key checkpoint molecules in the immune responses associated to skin inflammation and malignant transformation